Morgan Stanley
-
-
-
-
-
-
-
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs, Raising Gross Proceeds of $345 Million and Full Exercise of Underwriters' Option to Purchase Additional ADSs
-
-
-
-
-
-
-
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4 Million and Full Exercise of Underwriter’s Option to Purchase Additional ADSs
-
-
-
-
-
-
-
Morgan Stanley Sees Favorable GW Pharma (GWPH) Entry Point Ahead of Second LGS Trial Data
-
-
-
-
-
-
-
GW Pharmaceuticals (GWPH) to Offer $150M in ADSs
-
-
-
-
-
-
-
GW Pharmaceuticals plc Reports Third Quarter 2015 Financial Results and Operational Progress
-
-
-
-
-
-
-
GW Pharmaceuticals Announces Proposed Public Offering of ADSs
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 04/22: (GWPH) (IIN) (IDRA) Higher; (MDSO) (ARTX) (LXK) Lower
-
211,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

